Key result
Initial therapy with fluids, calcium, and adrenoreceptor agonists, guided by hemodynamic monitoring to determine shock etiology, is recommended for managing calcium channel blocker overdose.
Hemodynamic monitoring to differentiate cardiogenic shock from vasoplegia can guide the multifaceted treatment of calcium channel blocker overdose.
May support hemodynamic differentiation in CCB overdose; hypothesis-generating and requires prospective validation.
Calcium channel blocker toxicity can be devastating. Initial therapy with fluid, calcium, and adrenoreceptor agonists should be prompt and novel therapies can be added if no response. Determining cardiogenic shock versus vasoplegia with echocardiogram or other hemodynamic monitoring may guide treatment options.
No takes yet. Share an insight, caveat, or question.
Burkes et al. (2015) studied this question. Initial therapy with fluids, calcium, and adrenoreceptor agonists, guided by hemodynamic monitoring to determine shock etiology, is recommended for managing calcium channel blocker overdose.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: